FDA Enforcement Report Details Ongoing Class III Recall of Dabigatran Etexilate Capsules
FDA enforcement records detail an ongoing recall of 2,717 cartons of Dabigatran etexilate Capsules distributed nationwide.
Recalls & Safety Alerts in Bedminster, New Jersey
Every recalls & safety alerts report published for Bedminster, New Jersey, newest first.
FDA Enforcement Report Lists Ongoing Class III Recall of Dabigatran Etexilate Capsules
Ascend Laboratories, LLC is recalling one lot of 75 mg Dabigatran Etexilate Capsules nationwide after a stability test failed impurity limits, according to the FDA enforcement record.
FDA Reports Class III Recall of Dabigatran Etexilate Capsules
Ascend Laboratories, LLC is conducting a nationwide Class III recall of one lot of 75 mg dabigatran etexilate capsules due to failed impurity specifications, according to FDA records.
Ascend Laboratories Recalls Dabigatran Etexilate Capsules Over Impurity Test Results
An official FDA report lists an ongoing nationwide Class III recall for one lot of prescription medication.
FDA Records Class II Recall of 6,192 Bottles of Blood-Pressure Combination Tablets
An FDA enforcement report lists an ongoing nationwide recall of one lot of amlodipine and olmesartan medoxomil tablets distributed by Ascend Laboratories over failed dissolution specifications.